Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 20, 2022
The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2
Cristina González-Mingot, Ricard López-Ortega, Luis Brieva-Ruiz
Frontiers in Neurology
|
June 20, 2019
Cognitive Dysfunctions and Assessments in Multiple Sclerosis
Celia Oreja-Guevara, Teresa Ayuso Blanco, Luis Brieva Ruiz, et al.
The Journal of Headache and Pain
|
September 15, 2022
Preventive treatment can reverse cognitive impairment in chronic migraine
Cristina González-Mingot, Anna Gil-Sánchez, Marc Canudes-Solans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 20, 2026
Diminishing returns of disease-modifying treatment in older participants of MS clinical trials
Eva Strijbis, Jop Mostert, Miguel D'Haeseleer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 22, 2022
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
Patrick Vermersch, Luis Brieva-Ruiz, Robert J Fox, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 8, 2025
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study
Victoria M Leavitt, Robert Fox, Jop Mostert, et al.
Journal of Medical Economics
|
June 24, 2026
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis
Celia Oreja-Guevara, Lamberto Landete, Miguel Ángel Rodriguez Sagrado, et al.
Scientific Reports
|
November 8, 2023
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
Cristina González Mingot, Sonia Santos Lasaosa, Laura Colàs Campàs, et al.
The International Journal of Neuroscience
|
May 5, 2016
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients
Anna Gil Sánchez, Eugenia Lacasa Andrade, Joan Valls Marsal, et al.
Therapeutic Advances in Neurological Disorders
|
November 1, 2024
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management
Celia Oreja-Guevara, Sergio Martínez-Yélamos, Sara Eichau, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 20, 2022
The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2
Cristina González-Mingot, Ricard López-Ortega, Luis Brieva-Ruiz
Frontiers in Neurology
|
June 20, 2019
Cognitive Dysfunctions and Assessments in Multiple Sclerosis
Celia Oreja-Guevara, Teresa Ayuso Blanco, Luis Brieva Ruiz, et al.
The Journal of Headache and Pain
|
September 15, 2022
Preventive treatment can reverse cognitive impairment in chronic migraine
Cristina González-Mingot, Anna Gil-Sánchez, Marc Canudes-Solans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 20, 2026
Diminishing returns of disease-modifying treatment in older participants of MS clinical trials
Eva Strijbis, Jop Mostert, Miguel D'Haeseleer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 22, 2022
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
Patrick Vermersch, Luis Brieva-Ruiz, Robert J Fox, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 8, 2025
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study
Victoria M Leavitt, Robert Fox, Jop Mostert, et al.
Journal of Medical Economics
|
June 24, 2026
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis
Celia Oreja-Guevara, Lamberto Landete, Miguel Ángel Rodriguez Sagrado, et al.
Scientific Reports
|
November 8, 2023
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
Cristina González Mingot, Sonia Santos Lasaosa, Laura Colàs Campàs, et al.
The International Journal of Neuroscience
|
May 5, 2016
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients
Anna Gil Sánchez, Eugenia Lacasa Andrade, Joan Valls Marsal, et al.
Therapeutic Advances in Neurological Disorders
|
November 1, 2024
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management
Celia Oreja-Guevara, Sergio Martínez-Yélamos, Sara Eichau, et al.
Page
of 1